July 2 (Reuters) - Viatris unit Mylan is no longer a subject of the U.S. Department of Justice's antitrust investigation into alleged price fixing in the generic drug industry, 비아그라 정품 the parent company said on Tuesday. Mylan and several major 비아그라 부작용 drugmakers such as Israel's Teva Pharmaceutical Industries and India's Sun Pharmaceutical Industries have ...